Effects of 12-0-Tetradecanoylphorbol-13-acetate (TPA) on rat pheochromocytoma (PC12) cells: interactions with epidermal growth factor and nerve growth factor

Journal of Cellular Physiology
D EndG Guroff

Abstract

The phorbol ester tumor promotor 12-0-tetradecanoylphorbol-13-acetate (TPA) specifically inhibited the binding of radioiodinated epidermal growth factor (125I-EGF) to rat pheochromocytoma (PC12) cells in a noncompetitive fashion with an apparent Ki of 11-26 nM. Both TPA and EGF elicited similar biological responses in PC12 cells including enhanced incorporation of 3H-choline and 32 P-orthophosphate into macromolecules, induction of ornithine decarboxylase, and stimulation of the phosphorylation of a 30,000 MW nonhistone, chromosome-associated protein. These effects were also elicited by nerve growth fact (NGF) which, in contrast to the former agents, is a differentiating stimulus for PC12 cells. The effects of TPA were additive or more than additive to the effects of NGF and EGF. When PC12 cells were induced to differentiate by treatment with NGF for 72 hours, the binding of 125I-EGF and responses to EGF were reduced by approximately 70%. The response of PC12 cells to the tumor promoter TPA was unaffected by treatment with NGF. Thus, the qualitatively similar effects of TPA and EGF seemed to be mediated through separate receptor systems with only the EGF receptor system reduced by NGF treatment.

References

Oct 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·P D Gorin, E M Johnson
Aug 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·J E de Larco, G J Todaro
Dec 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·D E Burstein, L A Greene
Oct 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·L S Lee, I B Weinstein
Jun 1, 1979·Biochimica Et Biophysica Acta·T W KenslerG C Mueller
Jun 1, 1979·Journal of Cellular Physiology·L S Lee, I B Weinstein
Jan 1, 1976·Experientia·S P RoseH Herschman
Jan 22, 1976·Nature·M Wigler, I B Weinstein
Jan 1, 1969·Progress in Experimental Tumor Research·B L Van Duuren
May 15, 1974·International Journal of Cancer. Journal International Du Cancer·L DiamondY Shimizu
Oct 1, 1969·Proceedings of the National Academy of Sciences of the United States of America·V Bocchini, P U Angeletti
Jun 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·P Cuatrecasas
Jul 1, 1968·The Biochemical Journal·A E Pegg, H G Williams-Ashman
Mar 1, 1969·Archives of Biochemistry and Biophysics·S Panyim, R Chalkley
Jan 1, 1980·Cell Biology International Reports·J F Lechner, M E Kaighn
Aug 16, 1980·Molecular and Cellular Biochemistry·J Abrahm, G Rovera
Jan 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·P E Driedger, P M Blumberg

❮ Previous
Next ❯

Citations

Jan 1, 1988·Molecular Neurobiology·A LeviP Calissano
May 1, 1991·Molecular and Cellular Endocrinology·G Scalabrino, E C Lorenzini
Jul 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·D J KelleherG L Johnson
Jun 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·N E OlashawW J Pledger
Jul 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·J Milbrandt
Apr 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·T HamaG Guroff
Nov 1, 1984·The Journal of Clinical Investigation·M W LongL A Boxer
Mar 1, 1989·Environmental Health Perspectives·K FujitaG Guroff
Nov 1, 1991·Journal of Neurochemistry·A B Brown, G Carpenter
Jan 1, 1990·Nouvelle Revue Française D'hématologie·Z C HanJ P Caen
Jan 1, 1989·Annals of the New York Academy of Sciences·M W Long
Nov 29, 1991·Brain Research·R O MessingJ J Park
Jun 1, 1987·Journal of Cellular Biochemistry·N E Olashaw, W J Pledger
Aug 12, 1983·Biochemical and Biophysical Research Communications·A TogariG Guroff

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.